EAST WINDSOR, N.J. — Aurobindo Pharma USA (Aurobindo) has proposed the acquisition of Lannett Co. (Lannett). The company says it anticipates closing the acquisition towards the middle of calendar 2026, subject to regulatory approval.
"Over the coming months, we will be providing additional updates on this exciting acquisition and how we expect it to enable us to better serve you, our valued customer," said Paul McMahon, president, APUSA Oral Solids Division at Aurobindo. "In the meantime, until the transaction closes, it will be business as usual in every respect with both Aurobindo and Lannett continuing to operate as separate entities. Please continue to work with your respective points of contact at Aurobindo and Lannett for any of your normal day-to-day business needs regarding the respective product portfolios, operational and transactional matters, etc," he added.
Aurobindo to purchase Lannett Co.
The company says it anticipates closing the acquisition towards the middle of calendar 2026, subject to regulatory approval.
Related
Biosimilars Council and AAM endorse House bill to streamline biosimilar development
The Expedited Access to Biosimilars Act would codify the FDA's science-based approach to biosimilar review by limiting comparative efficacy studies.
PCMA adds public affairs leaders
The new hires strengthen the association’s advocacy, coalition-building, and stakeholder engagement capabilities at the state and federal levels.
CVS Caremark settles with FTC; PBM will advance transparency and affordability
The settlement resolves all outstanding FTC litigation and investigations related to CVS Health.
Amazon Pharmacy, eNavvi partner to provide transparent drug pricing, fast home delivery options
The integration is designed to support medication adherence and increase access, especially for patients in pharmacy deserts.c
Latest
Biosimilars Council and AAM endorse House bill to streamline biosimilar development
The Expedited Access to Biosimilars Act would codify the FDA's science-based approach to biosimilar review by limiting comparative efficacy studies.
Beauty at Walmart gets makeover
Shoppers can currently find Beauty 2.0 in some 150 Walmart stores, with 300 more conversions expected by the end of 2026.
Expect B-T-S shoppers to favor stores
The takeaway for retailers isn’t to shout louder about price. It’s to prove, aisle by aisle, that being in-store still delivers what shoppers need, when they need it.
PCMA adds public affairs leaders
The new hires strengthen the association’s advocacy, coalition-building, and stakeholder engagement capabilities at the state and federal levels.